Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

Similar articles for PubMed (Select 19812458)

1.

Cardiorespiratory fitness and preserved medial temporal lobe volume in Alzheimer disease.

Honea RA, Thomas GP, Harsha A, Anderson HS, Donnelly JE, Brooks WM, Burns JM.

Alzheimer Dis Assoc Disord. 2009 Jul-Sep;23(3):188-97. doi: 10.1097/WAD.0b013e31819cb8a2.

2.

Cardiorespiratory fitness and brain atrophy in early Alzheimer disease.

Burns JM, Cronk BB, Anderson HS, Donnelly JE, Thomas GP, Harsha A, Brooks WM, Swerdlow RH.

Neurology. 2008 Jul 15;71(3):210-6. doi: 10.1212/01.wnl.0000317094.86209.cb.

3.

Apolipoprotein E and gray matter volume loss in patients with mild cognitive impairment and Alzheimer disease.

Spampinato MV, Rumboldt Z, Hosker RJ, Mintzer JE; Alzheimer's Disease Neuroimaging Initiative.

Radiology. 2011 Mar;258(3):843-52. doi: 10.1148/radiol.10100307. Epub 2010 Dec 16.

PMID:
21163916
4.

APOE-epsilon4 is associated with less frontal and more medial temporal lobe atrophy in AD.

Geroldi C, Pihlajamäki M, Laakso MP, DeCarli C, Beltramello A, Bianchetti A, Soininen H, Trabucchi M, Frisoni GB.

Neurology. 1999 Nov 10;53(8):1825-32.

PMID:
10563634
5.

3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease.

Whitwell JL, Przybelski SA, Weigand SD, Knopman DS, Boeve BF, Petersen RC, Jack CR Jr.

Brain. 2007 Jul;130(Pt 7):1777-86. Epub 2007 May 28.

6.

Apolipoprotein E epsilon4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementia.

Agosta F, Vossel KA, Miller BL, Migliaccio R, Bonasera SJ, Filippi M, Boxer AL, Karydas A, Possin KL, Gorno-Tempini ML.

Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):2018-22. doi: 10.1073/pnas.0812697106. Epub 2009 Jan 22.

7.

Anatomically-distinct genetic associations of APOE epsilon4 allele load with regional cortical atrophy in Alzheimer's disease.

Filippini N, Rao A, Wetten S, Gibson RA, Borrie M, Guzman D, Kertesz A, Loy-English I, Williams J, Nichols T, Whitcher B, Matthews PM.

Neuroimage. 2009 Feb 1;44(3):724-8. doi: 10.1016/j.neuroimage.2008.10.003. Epub 2008 Nov 1.

PMID:
19013250
8.

Comprehensive dissection of the medial temporal lobe in AD: measurement of hippocampus, amygdala, entorhinal, perirhinal and parahippocampal cortices using MRI.

Teipel SJ, Pruessner JC, Faltraco F, Born C, Rocha-Unold M, Evans A, Möller HJ, Hampel H.

J Neurol. 2006 Jun;253(6):794-800. Epub 2006 Mar 6.

PMID:
16511646
9.

Apolipoprotein E epsilon4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias.

Barber R, Gholkar A, Scheltens P, Ballard C, McKeith IG, Morris CM, O'Brien JT.

Arch Neurol. 1999 Aug;56(8):961-5.

PMID:
10448801
10.

Family history of Alzheimer disease predicts hippocampal atrophy in healthy middle-aged adults.

Okonkwo OC, Xu G, Dowling NM, Bendlin BB, Larue A, Hermann BP, Koscik R, Jonaitis E, Rowley HA, Carlsson CM, Asthana S, Sager MA, Johnson SC.

Neurology. 2012 May 29;78(22):1769-76. doi: 10.1212/WNL.0b013e3182583047. Epub 2012 May 16.

11.

Cardiorespiratory fitness is associated with atrophy in Alzheimer's and aging over 2 years.

Vidoni ED, Honea RA, Billinger SA, Swerdlow RH, Burns JM.

Neurobiol Aging. 2012 Aug;33(8):1624-32. doi: 10.1016/j.neurobiolaging.2011.03.016. Epub 2011 May 4.

12.

Impact of APOE on the healthy aging brain: a voxel-based MRI and DTI study.

Honea RA, Vidoni E, Harsha A, Burns JM.

J Alzheimers Dis. 2009;18(3):553-64. doi: 10.3233/JAD-2009-1163.

13.

Inferior temporal lobe atrophy and APOE genotypes in Alzheimer's disease. X-ray computed tomography, magnetic resonance imaging and Xe-133 SPECT studies.

Tanaka S, Kawamata J, Shimohama S, Akaki H, Akiguchi I, Kimura J, Ueda K.

Dement Geriatr Cogn Disord. 1998 Mar-Apr;9(2):90-8.

PMID:
9524800
14.

Greater medial temporal hypometabolism and lower cortical amyloid burden in ApoE4-positive AD patients.

Lehmann M, Ghosh PM, Madison C, Karydas A, Coppola G, O'Neil JP, Huang Y, Miller BL, Jagust WJ, Rabinovici GD.

J Neurol Neurosurg Psychiatry. 2014 Mar;85(3):266-73. doi: 10.1136/jnnp-2013-305858. Epub 2013 Aug 21.

15.

Progressive regional atrophy in normal adults with a maternal history of Alzheimer disease.

Honea RA, Swerdlow RH, Vidoni ED, Burns JM.

Neurology. 2011 Mar 1;76(9):822-9. doi: 10.1212/WNL.0b013e31820e7b74.

16.

Multicentre variability of MRI-based medial temporal lobe volumetry in Alzheimer's disease.

Teipel SJ, Ewers M, Wolf S, Jessen F, Kölsch H, Arlt S, Luckhaus C, Schönknecht P, Schmidtke K, Heuser I, Frölich L, Ende G, Pantel J, Wiltfang J, Rakebrandt F, Peters O, Born C, Kornhuber J, Hampel H.

Psychiatry Res. 2010 Jun 30;182(3):244-50. doi: 10.1016/j.pscychresns.2010.03.003. Epub 2010 May 20.

PMID:
20493672
17.

Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease.

Honea RA, Swerdlow RH, Vidoni ED, Goodwin J, Burns JM.

Neurology. 2010 Jan 12;74(2):113-20. doi: 10.1212/WNL.0b013e3181c918cb.

18.

Neuroimaging biomarkers for Alzheimer's disease in asymptomatic APOE4 carriers.

Chételat G, Fouquet M.

Rev Neurol (Paris). 2013 Oct;169(10):729-36. doi: 10.1016/j.neurol.2013.07.025. Epub 2013 Sep 6. Review.

PMID:
24016463
19.

Different patterns of gray matter atrophy in early- and late-onset Alzheimer's disease.

Möller C, Vrenken H, Jiskoot L, Versteeg A, Barkhof F, Scheltens P, van der Flier WM.

Neurobiol Aging. 2013 Aug;34(8):2014-22. doi: 10.1016/j.neurobiolaging.2013.02.013. Epub 2013 Apr 3.

PMID:
23561509
20.

Reduced medial temporal lobe N-acetylaspartate in cognitively impaired but nondemented patients.

Chao LL, Schuff N, Kramer JH, Du AT, Capizzano AA, O'Neill J, Wolkowitz OM, Jagust WJ, Chui HC, Miller BL, Yaffe K, Weiner MW.

Neurology. 2005 Jan 25;64(2):282-9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk